1. Home
  2. ADV vs EOLS Comparison

ADV vs EOLS Comparison

Compare ADV & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advantage Solutions Inc.

ADV

Advantage Solutions Inc.

HOLD

Current Price

$40.36

Market Cap

438.2M

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.73

Market Cap

407.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADV
EOLS
Founded
1987
2012
Country
United States
United States
Employees
73000
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
438.2M
407.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ADV
EOLS
Price
$40.36
$6.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$45.83
$15.50
AVG Volume (30 Days)
97.2K
694.1K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
$0.63
$13.27
Revenue Next Year
$0.45
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$0.49
$3.86
52 Week High
$46.80
$10.20

Technical Indicators

Market Signals
Indicator
ADV
EOLS
Relative Strength Index (RSI) 59.44 60.19
Support Level $0.93 $5.95
Resistance Level $43.50 $7.29
Average True Range (ATR) 3.14 0.36
MACD -0.30 -0.02
Stochastic Oscillator 61.77 82.32

Price Performance

Historical Comparison
ADV
EOLS

About ADV Advantage Solutions Inc.

Advantage Solutions Inc provides outsourced sales, marketing, merchandising, sampling, and retailer support services to consumer packaged goods manufacturers and retailers across North America. Its services are designed to support distribution, retail execution, shopper engagement, and private brand development across both physical and digital commerce environments. The company serves various clients across grocery, mass, club, retail pharmacy, convenience, and other channels. It operates through three reportable segments: Branded Services, Experiential Services, and Retailer Services. The majority of the revenue is derived from the Experiential Services segment, which provides in-store and digital sampling programs, demonstrations, and experiential events for manufacturers and retailers.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: